Nucleotide excision repair and neurological diseases

DNA Repair

Volumn 7, Issue 7, 2008, Pages 1155-1167

  Nouspikel, Thierry ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Neurological diseases; Neurological dysfunctions; Nucleotide excision repair

Indexed keywords

ALZHEIMER DISEASE; ARTICLE; COCKAYNE SYNDROME; EXCISION REPAIR; GENETIC MODEL; GENETIC TRANSCRIPTION; NEUROLOGIC DISEASE; OXIDATIVE STRESS; PRIORITY JOURNAL; XERODERMA PIGMENTOSUM;

COCKAYNE SYNDROME; DNA REPAIR; HUMANS; MODELS, BIOLOGICAL; NERVOUS SYSTEM DISEASES; NEURONS; TRANSCRIPTION, GENETIC; XERODERMA PIGMENTOSUM;

EID: 44949126999     PISSN: 15687864     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dnarep.2008.03.015     Document Type: Article

References (93)

1. Wood R.D. DNA damage recognition during nucleotide excision repair in mammalian cells. Biochimie 81 (1999) 39-44
2. Tang J., and Chu G. Xeroderma pigmentosum complementation group E and UV-damaged DNA-binding protein. DNA Repair (Amst.) 1 (2002) 601-616
3. Akoulitchev S., Makela T.P., Weinberg R.A., and Reinberg D. Requirement for TFIIH kinase activity in transcription by RNA polymerase II. Nature 377 (1995) 557-560
4. Fiedler U., and Marc Timmers H.T. Peeling by binding or twisting by cranking: models for promoter opening and transcription initiation by RNA polymerase II. Bioessays 22 (2000) 316-326
5. Winkler G.S., Araujo S.J., Fiedler U., Vermeulen W., Coin F., Egly J.M., Hoeijmakers J.H., Wood R.D., Timmers H.T., and Weeda G. TFIIH with inactive XPD helicase functions in transcription initiation but is defective in DNA repair. J. Biol. Chem. 275 (2000) 4258-4266
6. Coin F., Oksenych V., and Egly J.M. Distinct roles for the XPB/p52 and XPD/p44 subcomplexes of TFIIH in damaged DNA opening during nucleotide excision repair. Mol. Cell 26 (2007) 245-256
7. Bohr V.A., Smith C.A., Okumoto D.S., and Hanawalt P.C. DNA repair in an active gene: removal of pyrimidine dimers from the DHFR gene of CHO cells is much more efficient than in the genome overall. Cell 40 (1985) 359-369
8. Mellon I., Spivak G., and Hanawalt P.C. Selective removal of transcription-blocking DNA damage from the transcribed strand of the mammalian DHFR gene. Cell 51 (1987) 241-249
9. Hanawalt P.C. Subpathways of nucleotide excision repair and their regulation. Oncogene 21 (2002) 8949-8956
10. Lehmann A.R. DNA repair-deficient diseases, xeroderma pigmentosum, Cockayne syndrome and trichothiodystrophy. Biochimie 85 (2003) 1101-1111
11. Crovato F., Borrone C., and Rebora A. Trichothiodystrophy-BIDS IBIDS and PIBIDS?. Br. J. Dermatol. 108 (1983) 247
12. Del Bigio M.R., Greenberg C.R., Rorke L.B., Schnur R., McDonald-McGinn D.M., and Zackai E.H. Neuropathological findings in eight children with cerebro-oculo-facio-skeletal (COFS) syndrome. J. Neuropathol. Exp. Neurol. 56 (1997) 1147-1157
13. Spivak G. UV-sensitive syndrome. Mutat. Res. 577 (2005) 162-169
14. Nouspikel T. DNA repair in differentiated cells: some new answers to old questions. Neuroscience 145 (2007) 1213-1221
15. Jensen L., and Linn S. A reduced rate of bulky DNA adduct removal is coincident with differentiation of human neuroblastoma cells induced by nerve growth factor. Mol. Cell. Boil. 8 (1988) 3964-3968
16. Nouspikel T., and Hanawalt P.C. Terminally differentiated human neurons repair transcribed genes but display attenuated global DNA repair and modulation of repair gene expression. Mol. Cell. Biol. 20 (2000) 1562-1570
17. Nouspikel T., and Hanawalt P.C. DNA repair in terminally differentiated cells. DNA Repair 1 (2002) 59-75
18. Ho L., and Hanawalt P.C. Gene-specific DNA repair in terminally differentiating rat myoblasts. Mutat. Res. DNA Repair 255 (1991) 124-141
19. Hsu P.S., Hanawalt P.C., and Nouspikel T. Nucleotide excision repair phenotype of human acute myeloid leukemia cell lines at various stages of differentiation. Mutat. Res. 614 (2007) 3-15
20. Liu S.C., Parsons S., and Hanawalt P.C. DNA repair in cultured keratinocytes. J. Invest. Dermatol. 81 (1983) 179s-183s
21. Eggset G., Volden G., and Krokan H. UV-induced DNA damage and its repair in human skin in vivo studied by sensitive immunohistochemical methods. Carcinogenesis 4 (1983) 745-750
22. Bielas J.H. Non-transcribed strand repair revealed in quiescent cells. Mutagenesis 21 (2006) 49-53
23. Nouspikel T.P., Hyka-Nouspikel N., and Hanawalt P.C. Transcription domain-associated repair in human cells. Mol. Cell. Biol. 26 (2006) 8722-8730
24. Nouspikel T., and Hanawalt P.C. Impaired nucleotide excision repair upon macrophage differentiation is corrected by E1 ubiquitin-activating enzyme. Proc. Natl. Acad. Sci. U.S.A. 103 (2006) 16188-16193
25. Yang Y., Geldmacher D.S., and Herrup K. DNA replication precedes neuronal cell death in Alzheimer's disease. J. Neurosci. 21 (2001) 2661-2668
26. Nouspikel T., and Hanawalt P.C. When parsimony backfires: neglecting DNA repair may doom neurons in Alzheimer's disease. BioEssays 25 (2003) 168-173
27. von Hebra F., and Kaposi M. On diseases of the skin, including the exanthemata. New Sydenham. Soc. 61 (1874) 252-258
28. Kaposi M. Xeroderma pigmentosum. Ann. Dermatol. Venerol. 4 (1882) 29-38
29. Kraemer K.H., Lee M.M., and Scotto J. Xeroderma pigmentosum. Cutaneous, ocular, and neurological abnormalities in 830 published cases. Arch. Dermatol. 123 (1987) 241-250
30. Kraemer K.H., Lee M.M., and Scotto J. DNA repair protects against cutaneous and internal neoplasia: evidence from xeroderma pigmentosum. Carcinogenesis 5 (1984) 511-514
31. Neisser A. Ueber das xeroderma pigmentosum. Lioderma essentialis cum melanosis et telangectasia. Jahrschr. Dermatol. Syphil. 1883 (1883) 47-62
32. DeSanctis C., and Cacchione A. L'idiozia xerodermica. Riv. Sper. Frentiatr. Med. Leg. Alienazioni Ment. 56 (1932) 269-292
33. Rapin I., Lindenbaum Y., Dickson D.W., Kraemer K.H., and Robbins J.H. Cockayne syndrome and xeroderma pigmentosum. Neurology 55 (2000) 1442-1449
34. Cleaver J.E. Defective repair replication of DNA in xeroderma pigmentosum. Nature 218 (1968) 652-656
35. Setlow R.B., Regan J.D., German J., and Carrier W.L. Evidence that xeroderma pigmentosum cells do not perform the first step in the repair of ultraviolet damage to their DNA. Proc. Natl. Acad. Sci. U.S.A. 64 (1969) 1035-1041
36. Masutani C., Kusumoto R., Yamada A., Dohmae N., Yokoi M., Yuasa M., Araki M., Iwai S., Takio K., and Hanaoka F. The XPV (xeroderma pigmentosum variant) gene encodes human DNA polymerase eta. Nature 399 (1999) 700-704
37. Jaspers N.G., Raams A., Silengo M.C., Wijgers N., Niedernhofer L.J., Robinson A.R., Giglia-Mari G., Hoogstraten D., Kleijer W.J., Hoeijmakers J.H., and Vermeulen W. First reported patient with human ERCC1 deficiency has cerebro-oculo-facio-skeletal syndrome with a mild defect in nucleotide excision repair and severe developmental failure. Am. J. Hum. Genet. 80 (2007) 457-466
38. Ng J.M., Vermeulen W., van der Horst G.T., Bergink S., Sugasawa K., Vrieling H., and Hoeijmakers J.H. A novel regulation mechanism of DNA repair by damage-induced and RAD23-dependent stabilization of xeroderma pigmentosum group C protein. Genes Dev. 17 (2003) 1630-1645
39. Sargent R.G., Meservy J.L., Perkins B.D., Kilburn A.E., Intody Z., Adair G.M., Nairn R.S., and Wilson J.H. Role of the nucleotide excision repair gene ERCC1 in formation of recombination-dependent rearrangements in mammalian cells. Nucleic Acids Res. 28 (2000) 3771-3778
40. Zhu X.D., Niedernhofer L., Kuster B., Mann M., Hoeijmakers J.H., and de Lange T. ERCC1/XPF removes the 3' overhang from uncapped telomeres and represses formation of telomeric DNA-containing double minute chromosomes. Mol Cell 12 (2003) 1489-1498
41. Weissman L., de Souza-Pinto N.C., Stevnsner T., and Bohr V.A. DNA repair, mitochondria, and neurodegeneration. Neuroscience 145 (2007) 1318-1329
42. Brooks P.J. The case for 8,5'-cyclopurine-2'-deoxynucleosides as endogenous DNA lesions that cause neurodegeneration in xeroderma pigmentosum. Neuroscience 145 (2007) 1407-1417
43. Johnson K.A., Fink S.P., and Marnett L.J. Repair of propanodeoxyguanosine by nucleotide excision repair in vivo and in vitro. J. Biol. Chem. 272 (1997) 11434-11438
44. Cline S.D., and Hanawalt P.C. Topoisomerase deficiencies subtly enhance global genomic repair of ultraviolet-induced DNA damage in Saccharomyces cerevisiae. DNA Repair (Amst.) 5 (2006) 611-617
45. Ljungman M., Zhang F., Chen F., Rainbow A.J., and McKay B.C. Inhibition of RNA polymerase II as a trigger for the p53 response. Oncogene 18 (1999) 583-592
46. Reed W.B., May S.B., and Nickel W.R. Xeroderma pigmentosum with neurological complications. Arch. Derm. 91 (1965) 224-226
47. Kanda T., Oda M., Yonezawa M., Tamagawa K., Isa F., Hanakago R., and Tsukagoshi H. Peripheral neuropathy in xeroderma pigmentosum. Brain 113 Pt 4 (1990) 1025-1044
48. Itoh T., Cleaver J.E., and Yamaizumi M. Cockayne syndrome complementation group B associated with xeroderma pigmentosum phenotype. Hum. Genet. 97 (1996) 176-179
49. Colella S., Nardo T., Botta E., Lehmann A.R., and Stefanini M. Identical mutations in the CSB gene associated with either Cockayne syndrome or the DeSanctis-cacchione variant of xeroderma pigmentosum. Hum. Mol. Genet. 9 (2000) 1171-1175
50. Cockayne A.E. Dwarfism with retinal atrophy and deafness. Arch. Dis. Child. 11 (1936) 1-8
51. Nance M.A., and Berry S.A. Cockayne syndrome: review of 140 cases. Am. J. Med. Genet. 42 (1992) 68-84
52. Lowry R.B. Early onset of Cockayne syndrome. Am. J. Med. Genet. 13 (1982) 209-210
53. Venema J., Mullenders L.H., Natarajan A.T., van Zeeland A.A., and Mayne L.V. The genetic defect in Cockayne syndrome is associated with a defect in repair of UV-induced DNA damage in transcriptionally active DNA. Proc. Natl. Acad. Sci. U.S.A. 87 (1990) 4707-4711
54. Mayne L.V., and Lehmann A.R. Failure of RNA synthesis to recover after UV irradiation: an early defect in cells from individuals with Cockayne's syndrome and xeroderma pigmentosum. Cancer Res. 42 (1982) 1473-1478
55. Shcherbakova P.V., and Fijalkowska I.J. Translesion synthesis DNA polymerases and control of genome stability. Front. Biosci. 11 (2006) 2496-2517
56. Bradsher J., Coin F., and Egly J.M. Distinct roles for the helicases of TFIIH in transcript initiation and promoter escape. J. Biol. Chem. 275 (2000) 2532-2538
57. van Gool A.J., Citterio E., Rademakers S., van Os R., Vermeulen W., Constantinou A., Egly J.M., Bootsma D., and Hoeijmakers J.H. The Cockayne syndrome B protein, involved in transcription-coupled DNA repair, resides in an RNA polymerase II-containing complex. EMBO J. 16 (1997) 5955-5965
58. Selby C.P., and Sancar A. Cockayne syndrome group B protein enhances elongation by RNA polymerase II. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 11205-11209
59. Balajee A.S., May A., Dianov G.L., Friedberg E.C., and Bohr V.A. Reduced RNA polymerase II transcription in intact and permeabilized Cockayne syndrome group B cells. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 4306-4311
60. Dianov G.L., Houle J.F., Iyer N., Bohr V.A., and Friedberg E.C. Reduced RNA polymerase II transcription in extracts of cockayne syndrome and xeroderma pigmentosum/Cockayne syndrome cells. Nucleic Acids Res. 25 (1997) 3636-3642
61. Chu G., and Mayne L. Xeroderma pigmentosum Cockayne syndrome and trichothiodystrophy: do the genes explain the diseases?. Trends Genet. 12 (1996) 187-192
62. Jost J.P., Siegmann M., Sun L., and Leung R. Mechanisms of DNA demethylation in chicken embryos. Purification and properties of a 5-methylcytosine-DNA glycosylase. J. Biol. Chem. 270 (1995) 9734-9739
63. Jost J.P., Schwarz S., Hess D., Angliker H., Fuller-Pace F.V., Stahl H., Thiry S., and Siegmann M. A chicken embryo protein related to the mammalian DEAD box protein p68 is tightly associated with the highly purified protein-RNA complex of 5-MeC-DNA glycosylase. Nucleic Acids Res. 27 (1999) 3245-3252
64. Scherly D., Nouspikel T., Corlet J., Ucla C., Bairoch A., and Clarkson S.G. Complementation of the DNA repair defect in xeroderma pigmenstosum group G cells by a human cDNA related to yeast RAD2. Nature 363 (1993) 182-184
65. Ito S., Kuraoka I., Chymkowitch P., Compe E., Takedachi A., Ishigami C., Coin F., Egly J.M., and Tanaka K. XPG stabilizes TFIIH, allowing transactivation of nuclear receptors: implications for Cockayne syndrome in XP-G/CS patients. Mol. Cell 26 (2007) 231-243
66. Nouspikel T., Lalle P., Leadon S.A., Cooper P.K., and Clarkson S.G. A common mutational pattern in Cockayne syndrome patients from xeroderma pigmentosum group G: implications for a second XPG function. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 3116-3121
67. Lein E.S., Hawrylycz M.J., Ao N., Ayres M., Bensinger A., Bernard A., Boe A.F., Boguski M.S., Brockway K.S., Byrnes E.J., Chen L., Chen L., Chen T.M., Chin M.C., Chong J., Crook B.E., Czaplinska A., Dang C.N., Datta S., Dee N.R., Desaki A.L., Desta T., Diep E., Dolbeare T.A., Donelan M.J., Dong H.W., Dougherty J.G., Duncan B.J., Ebbert A.J., Eichele G., Estin L.K., Faber C., Facer B.A., Fields R., Fischer S.R., Fliss T.P., Frensley C., Gates S.N., Glattfelder K.J., Halverson K.R., Hart M.R., Hohmann J.G., Howell M.P., Jeung D.P., Johnson R.A., Karr P.T., Kawal R., Kidney J.M., Knapik R.H., Kuan C.L., Lake J.H., Laramee A.R., Larsen K.D., Lau C., Lemon T.A., Liang A.J., Liu Y., Luong L.T., Michaels J., Morgan J.J., Morgan R.J., Mortrud M.T., Mosqueda N.F., Ng L.L., Ng R., Orta G.J., Overly C.C., Pak T.H., Parry S.E., Pathak S.D., Pearson O.C., Puchalski R.B., Riley Z.L., Rockett H.R., Rowland S.A., Royall J.J., Ruiz M.J., Sarno N.R., Schaffnit K., Shapovalova N.V., Sivisay T., Slaughterbeck C.R., Smith S.C., Smith K.A., Smith B.I., Sodt A.J., Stewart N.N., Stumpf K.R., Sunkin S.M., Sutram M., Tam A., Teemer C.D., Thaller C., Thompson C.L., Varnam L.R., Visel A., Whitlock R.M., Wohnoutka P.E., Wolkey C.K., Wong V.Y., Wood M., Yaylaoglu M.B., Young R.C., Youngstrom B.L., Yuan X.F., Zhang B., Zwingman T.A., and Jones A.R. Genome-wide atlas of gene expression in the adult mouse brain. Nature 445 (2007) 168-176
68. van Oosterwijk M.F., Versteeg A., Filon R., van Zeeland A.A., and Mullenders L.H. The sensitivity of Cockayne's syndrome cells to DNA-damaging agents is not due to defective transcription-coupled repair of active genes. Mol. Cell. Biol. 16 (1996) 4436-4444
69. van Oosterwijk M.F., Filon R., Kalle W.H., Mullenders L.H., and van Zeeland A.A. The sensitivity of human fibroblasts to N-acetoxy-2-acetylaminofluorene is determined by the extent of transcription-coupled repair, and/or their capability to counteract RNA synthesis inhibition. Nucleic Acids Res. 24 (1996) 4653-4659
70. van Oosterwijk M.F., Filon R., de Groot A.J., van Zeeland A.A., and Mullenders L.H. Lack of transcription-coupled repair of acetylaminofluorene DNA adducts in human fibroblasts contrasts their efficient inhibition of transcription. J. Biol. Chem. 273 (1998) 13599-13604
71. Tornaletti S., Reines D., and Hanawalt P.C. Structural characterization of RNA polymerase II complexes arrested by a cyclobutane pyrimidine dimer in the transcribed strand of template DNA. J. Biol. Chem. 274 (1999) 24124-24130
72. Tijsterman M., and Brouwer J. Rad26, the yeast homolog of the cockayne syndrome B gene product, counteracts inhibition of DNA repair due to RNA polymerase II transcription. J. Biol. Chem. 274 (1999) 1199-1202
73. Svejstrup J.Q. Mechanisms of transcription-coupled DNA repair. Nat. Rev. Mol. Cell. Biol. 3 (2002) 21-29
74. Fousteri M., Vermeulen W., van Zeeland A.A., and Mullenders L.H. Cockayne syndrome A and B proteins differentially regulate recruitment of chromatin remodeling and repair factors to stalled RNA polymerase II in vivo. Mol. Cell 23 (2006) 471-482
75. Sarker A.H., Tsutakawa S.E., Kostek S., Ng C., Shin D.S., Peris M., Campeau E., Tainer J.A., Nogales E., and Cooper P.K. Recognition of RNA polymerase II and transcription bubbles by XPG, CSB, and TFIIH: insights for transcription-coupled repair and Cockayne Syndrome. Mol. Cell 20 (2005) 187-198
76. Bregman D.B., Halaban R., van Gool A.J., Henning K.A., Friedberg E.C., and Warren S.L. UV-induced ubiquitination of RNA polymerase II: a novel modification deficient in Cockayne syndrome cells. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 11586-11590
77. Groisman R., Polanowska J., Kuraoka I., Sawada J., Saijo M., Drapkin R., Kisselev A.F., Tanaka K., and Nakatani Y. The ubiquitin ligase activity in the DDB2 and CSA complexes is differentially regulated by the COP9 signalosome in response to DNA damage. Cell 113 (2003) 357-367
78. Groisman R., Kuraoka I., Chevallier O., Gaye N., Magnaldo T., Tanaka K., Kisselev A.F., Harel-Bellan A., and Nakatani Y. CSA-dependent degradation of CSB by the ubiquitin-proteasome pathway establishes a link between complementation factors of the Cockayne syndrome. Genes Dev. 20 (2006) 1429-1434
79. Tsutakawa S.E., and Cooper P.K. Transcription-coupled repair of oxidative DNA damage in human cells: mechanisms and consequences. Cold Spring Harb. Symp. Quant. Biol. 65 (2000) 201-215
80. Hanawalt P.C. DNA repair. The bases for Cockayne syndrome. Nature 405 (2000) 415-416
81. Mellon I. Transcription-coupled repair: a complex affair. Mutat. Res. 577 (2005) 155-161
82. Klungland A., Höss M., Gunz D., Constantinou A., Clarkson S.G., Doetsch P.W., Bolton P.H., Wood R.D., and Lindahl T. Base excision repair of oxidative DNA damage activated by XPG protein. Mol. Cell 3 (1999) 33-42
83. Bregeon D., Doddridge Z.A., You H.J., Weiss B., and Doetsch P.W. Transcriptional mutagenesis induced by uracil and 8-oxoguanine in Escherichia coli. Mol. Cell 12 (2003) 959-970
84. Spivak G., and Hanawalt P.C. Host cell reactivation of plasmids containing oxidative DNA lesions is defective in Cockayne syndrome but normal in UV-sensitive syndrome fibroblasts. DNA Repair (Amst.) 5 (2006) 13-22
85. Tornaletti S. Transcription arrest at DNA damage sites. Mutat. Res. 577 (2005) 131-145
86. Charlet-Berguerand N., Feuerhahn S., Kong S.E., Ziserman H., Conaway J.W., Conaway R., and Egly J.M. RNA polymerase II bypass of oxidative DNA damage is regulated by transcription elongation factors. EMBO J. 25 (2006) 5481-5491
87. Tornaletti S., Maeda L.S., Lloyd D.R., Reines D., and Hanawalt P.C. Effect of thymine glycol on transcription elongation by T7 RNA polymerase and mammalian RNA polymerase II. J. Biol. Chem. 276 (2001) 45367-45371
88. Tornaletti S., Maeda L.S., Kolodner R.D., and Hanawalt P.C. Effect of 8-oxoguanine on transcription elongation by T7 RNA polymerase and mammalian RNA polymerase II. DNA Repair (Amst.) 3 (2004) 483-494
89. Zhou W., and Doetsch P.W. Effects of abasic sites and DNA single-strand breaks on prokaryotic RNA polymerases. Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 6601-6605
90. Wang Y., Sheppard T.L., Tornaletti S., Maeda L.S., and Hanawalt P.C. Transcriptional inhibition by an oxidized abasic site in DNA. Chem. Res. Toxicol. 19 (2006) 234-241
91. Wilson III D.M., and McNeill D.R. Base excision repair and the central nervous system. Neuroscience 145 (2007) 1187-1200
92. LeDoux S.P., Druzhyna N.M., Hollensworth S.B., Harrison J.F., and Wilson G.L. Mitochondrial DNA repair: a critical player in the response of cells of the CNS to genotoxic insults. Neuroscience 145 (2007) 1249-1259
93. Spivak G. The many faces of Cockayne syndrome. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 15273-15274